PROG Made Headway
PROG (PROG:NASDAQ) jumped higher at $2.14, representing a gain of 58.5%. The stock got featured on our News Catalysts scanner on Tue, Sep 21, 2021 at 07:46 AM in the 'PATNERSHIP' category. From Fri, Sep 24, 2021, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Oct 01, 2021 at $2.2 with a volume of 247M+.
About PROG (PROG:NASDAQ)
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.
Top 10 Gainers:
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 93.86%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 75.05%
- Flexion Therapeutics, Inc. (FLXN:NASDAQ), 58.65%
- PROG (PROG:NASDAQ), 58.52%
- U.S. Well Services, Inc. (USWS:NASDAQ), 25.83%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 23.97%
- Sphere 3D Corp. (ANY:NASDAQ), 23.77%
- GOTU (GOTU:NYSE), 19.35%
- Blue Apron Holdings, Inc. (APRN:NYSE), 17.4%
- Hexindai Inc. (HX:NASDAQ), 15.44%